Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension
Clinical trial NCT00783094 · COMPLETED
Trial details
- NCT number
- NCT00783094
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.